JNJ is building a suite of heart disease treatment devices and hopes integration can help it avoid a patent cliff. More
Articles
CTNM Stock: 7 Things to Know as Contineum Therapeutics Starts Trading Today
Contineum Therapeutics stock is getting ready to start trading on Friday with plans for a $110 million IPO for shares of CTNM. More
FLGC Stock Earnings: Flora Growth Misses EPS, Beats Revenue for Q4 2023
FLGC stock results show that Flora Growth missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. More
GALT Stock Earnings: Galectin Therapeutics Meets EPS for Q4 2023
GALT stock results show that Galectin Therapeutics met analyst estimates for earnings per share the fourth quarter of 2023. More
FSI Stock Earnings: Flexible Solutions Intl Beats EPS, Beats Revenue for Q4 2023
FSI stock results show that Flexible Solutions Intl beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. More
EZFL Stock Earnings: EzFill Holdings Reported Results for Q4 2023
EzFill Holdings just reported results for the fourth quarter of 2023. More
GDC Stock Earnings: GD Culture Group Reported Results for Q4 2023
GD Culture Group just reported results for the fourth quarter of 2023. More
